1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- The β2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells
- 2016
- PBX3 is a putative biomarker of aggressive prostate cancer
- Low β2-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism.
- 2008
- Hormonal regulation of beta(2)-adrenergic receptor level in prostate cancer